Finance

Beta
Lists
PYXS:NASDAQ
Pyxis Oncology Inc
$1.70
-0.58%
(-0.0100) 1D
$1.70
0.00% (0.00)
After hours
Closed: Jun 3, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PYXS...
Open
$1.73
High
$1.75
Low
$1.67
Mkt. cap
107.70M
Avg. vol.
642.50K
Volume
179.22K
52-wk high
$5.55
52-wk low
$0.97
EPS
-$1.30
Beta
1.42
Shares outstanding
63.36M
No. of employees
56
Open
$1.73
High
$1.75
Low
$1.67
Mkt. cap
107.70M
Avg. vol.
642.50K
Volume
179.22K
52-wk high
$5.55
52-wk low
$0.97
EPS
-$1.30
Beta
1.42
Shares outstanding
63.36M
No. of employees
56
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to PYXS in the past 3 months
Strong Buy
Buy
6
Hold
1
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for PYXS in the last 3 months.
Highest
Current $1.70
$8.00 (+370.59%)
Average
$6.50 (+282.35%)
Lowest
$5.00 (+194.12%)
News stories
From sources across the web
About Pyxis Oncology Inc
CEO-
Employees56
Founded2018
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitepyxisoncology.com
Last report
May 14, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.37 / -$0.35
-4.72%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.82M
-
11.04M
-
Cost of goods sold
-
-
2.39M
-
Cost of revenue
-
-
2.39M
-
Research and development expenses
17.13M
17.81M
21.71M
19.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.75M
4.97M
4.54M
3.75M
Operating expense
21.89M
22.78M
26.25M
23.73M
Total operating expenses
21.89M
22.78M
28.64M
23.73M
Operating income
-19.07M
-22.78M
-17.60M
-23.73M
Other non operating income
-
-
-
-
EBT including unusual items
-18.07M
-22.00M
-17.00M
-23.27M
EBT excluding unusual items
-18.07M
-22.00M
-17.00M
-23.27M
Income tax expense
283.00K
-
1.10M
-
Effective tax rate
-1.57%
-
-6.49%
-
Other operating expenses
-
-
-
-
Net income
-18.35M
-22.00M
-18.11M
-23.27M
Net profit margin
-650.85%
-
-164.03%
-
Earnings per share
-0.30
-0.35
-0.29
-0.37
Interest and investment income
995.00K
774.00K
600.00K
457.00K
Interest expense
-
-
-
-
Net interest expenses
995.00K
774.00K
600.00K
457.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-18.53M
-22.25M
-14.71M
-22.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer